BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2006
View Archived Issues
Chemopreventative potential of the rexinoid bexarotene
Read More
Preclinical and clinical studies examine ocular effects of bevacizumab
Read More
Preclinical update on MLN-8054
Read More
Denileukin-mediated depletion of Tregs: an important anticancer strategy / News in Context
Read More
SUVN-501 elevates hippocampal levels of acetylcholine as a potential procognitive treatment
Read More
AdipoGenix and Unigen to develop plant-based therapeutics that target fat
Read More
Tigris studies A-007 in high-grade CIN
Read More
Isis transaction to fund drug development programs
Read More
Novartis seeks approvals for Glivec in rare cancers
Read More
FX-06 for reperfusion injury safe and well tolerated in phase I study
Read More
Affiris closes EUR 8.5 million financing round
Read More
Pfizer to acquire Rinat Neuroscience
Read More
Cardiome Pharma recaps Q4 highlights
Read More
TRO-19622: clinical candidate for motor neuron disease
Read More
Preclinical proof-of-concept for Myodur in DMD
Read More
European approval for Adartrel in RLS
Read More
Novel anti-HCV drugs reported by Merck and Istituto di Ricerche di Biologia Molecolare P. Angeletti
Read More
Recent Altana patent divulges new PDE2 inhibitors for septic shock
Read More
Recent patents describe new agents for anxiety, depression, sleep disorders, etc.
Read More
Heterotrimeric G-protein complex inhibitor BIM-46187 presented at AACR meeting
Read More
Update of Synta Pharmaceutical's STA-5326 mesylate under clinical investigation
Read More
Bone-targeted rapamycin analogue with both antitumor and antiosteolytic effects
Read More
Dasatinib shows clinical benefit in CML patients resistant to imatinib
Read More
Recombinant immunocytotoxic protein for ovarian cancer shows good preclinical profile
Read More
Preclinical data on a human conjugated monoclonal antibody developed by CuraGen
Read More